Daily News Podcast

Novel formulation for childhood ADHD

Publish date: November 20, 2018

 

A novel formulation of methylphenidate could provide morning relief to pediatric patients with attention-deficit hyperactivity disorder. Also today, CARE MD protocol could help treat somatic disorders, children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes, and ganglion stimulation boosts cerebral blood flow and improves stroke outcomes.
Amazon Alexa
Apple Podcasts
Google Podcasts

Recommended Reading

Trump rule and ACA contraception
MDedge Hematology and Oncology
How to slash colorectal surgery infection rates
MDedge Hematology and Oncology
‘Organoid technology’ poised to transform cancer care
MDedge Hematology and Oncology
Heart failure and sacubiril/valsartan
MDedge Hematology and Oncology
Vitamin D, fish out, and primary prevention
MDedge Hematology and Oncology
December 2018
MDedge Hematology and Oncology
USPSTF: screen for ‘unhealthy’ alcohol use
MDedge Hematology and Oncology
Obesity curbs decades of CVD progress
MDedge Hematology and Oncology
Physical fitness guidelines from HHS
MDedge Hematology and Oncology
Invasive strategy increased bleeding risk in frail older AMI patients
MDedge Hematology and Oncology